Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

NCT01208233 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

181

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Ischemic Stroke

Interventions

DRUG: PF-03049423
DRUG: PF-03049423
DRUG: PF-03049423
OTHER: Placebo

Sponsor

Pfizer